Research Letter
Abstract
This research letter characterizes racial/ethnic disparities in polysubstance use among 409 online help–seeking sexual and gender minoritized people in San Francisco. Findings demonstrate the central role of tobacco as a co-occurring substance for participants who are Black, Indigenous, and people of color compared to their White counterparts.
JMIR Public Health Surveill 2025;11:e82313doi:10.2196/82313
Keywords
Introduction
Polysubstance use, the concurrent or sequential use of more than 1 substance within a defined interval, is associated with multiple elevated health risks (eg, overdose, poor mental health, HIV) and disproportionately impacts sexual and gender minoritized (SGM) subgroups, such as transgender people and cisgender lesbian women [-]. Few studies have documented racial/ethnic disparities in polysubstance use among SGM populations []. Analyses of the 2021 National Survey on Drug Use and Health identified greater risk of polysubstance use among nonheterosexual respondents, illustrating SGM health disparities in substance use [], yet little is known about how these disparities emerge in the critical moments before seeking help, particularly among SGM individuals using online platforms, where opportunities for digital heath intervention may be most immediate and impactful to populations least likely to have access to supportive public health services [].
Methods
Study Design and Participants
We recruited 409 participants between 2022 and 2025 through Facebook, Instagram, and Grindr advertisements for individuals seeking help for substance use or treatment services and related topics (eg, HIV, mental health). Participants were eligible if they were men who have sex with men or transgender and gender expansive, were aged ≥18 years, were San Francisco residents, and had a mobile phone.
Measures
We measured the following sociodemographic characteristics: age, race/ethnicity, gender identity, sexual orientation, HIV serostatus, housing, and income. Race/ethnicity was recoded into a dichotomous variable (1 for Black, Indigenous, and people of color [BIPOC] and 0 for White). We measured substance use by asking participants how many days in the last 30 they used tobacco, vape devices, and alcohol; engaged in hazardous drinking; and used marijuana, prescription opioids (eg, pain relievers), nonprescription opioids (eg, heroin, fentanyl), other prescription drugs (used nonmedically), other illicit substances (eg, crack, cocaine, amphetamines, methamphetamine, hallucinogens, or inhalants such as poppers), and any injected drugs. For each substance, we created a dichotomous variable for any reported use at least once in the prior 30 days (yes/no). We measured past-30-day polysubstance use by assessing the prevalent combinations of pairs of substances used in the last 30 days.
Data Analysis
A correlation matrix heat map was used to illustrate the proportion of participants reporting each polysubstance use combination. We then constructed logistic regression models to examine associations between BIPOC identity and substance use pairs in the top quantile of prevalence (above 10% of the sample), adjusting for age, gender, sexual orientation, HIV status and housing stability, and socioeconomic status. Analyses were performed using R (version 2024.12.0). No missing data were recorded.
Ethical Considerations
The study protocol was approved by the University of California, San Francisco institutional review board (20-33169). Participants provided signed informed consent and were given a US$30 gift card for completing the assessment. Data were deidentified to protect participants’ privacy and confidentiality.
Results
BIPOC participants comprised 58.7% (240/409) of the sample, with the largest group being Latine (113/409, 27.6%), followed by Asian and Pacific Islander and Native Hawaiian (50/409, 12.2%), multiracial/other (39/409, 9.5%), and Black/African American (38/409, 9.3%). presents 2 matrices, stratified by BIPOC identity, for White participants and BIPOC participants. Tobacco appears more frequently as a co-occurring substance across all substance use behaviors among BIPOC participants compared to White participants. Use of a vape product was also notably higher as a co-occurring substance in all categories for BIPOC participants. In contrast, hazardous drinking was less prevalent among BIPOC participants (86/240, 35.8%) than among White participants (74/169, 43.8%). Regression models () identified 3 substance use combinations with higher odds of use among BIPOC participants compared to White participants: alcohol and tobacco (adjusted odds ratio [aOR] 1.61, 95% CI 1.00-2.64), illicit substances and tobacco (aOR 1.67, 95% CI 1.07-2.80), and marijuana and tobacco (aOR 1.78, 95% CI 1.07-3.03).


Discussion
We found that 3 combinations of polysubstance use involving tobacco—alcohol and tobacco, illicit substances and tobacco, and marijuana and tobacco—were more common among BIPOC participants than White participants. This pattern mirrors other research documenting higher tobacco use prevalence in BIPOC communities despite trending decreases in use nationwide []. This study has limited generalizability due to its cross-sectional study design, self-report bias, and its focus on online help–seeking individuals in San Francisco. Despite this, our results highlight a persistent gap in understanding how race intersects with tobacco use and its role in polysubstance use, particularly within minoritized populations actively seeking support online. Future research examining ecological dimensions of polysubstance use would further our understanding of the social context of polysubstance use.
Acknowledgments
The authors would like to thank all participants in the study. This work was funded by the Substance Abuse and Mental Health Service Administration (SAMHSA; award H79SP082077).
Data Availability
The datasets generated or analyzed during this study are not publicly available as they contain details that could be used to identify participants but are available from the corresponding author on reasonable request.
Conflicts of Interest
None declared.
References
- Flentje A, Sunder G, Ceja A, Lisha NE, Neilands TB, Aouizerat BE, et al. Substance use over time among sexual and gender minority people: differences at the intersection of sex and gender. LGBT Health. 2024;11(4):269-281. [FREE Full text] [CrossRef] [Medline]
- Cotaina M, Peraire M, Boscá M, Echeverria I, Benito A, Haro G. Substance use in the transgender population: a meta-analysis. Brain Sci. Mar 10, 2022;12(3):366. [FREE Full text] [CrossRef] [Medline]
- Mestre LM, White MA, Levy BR, Bold KW. Higher prevalence of polysubstance use among older lesbian, and gay US adults. Drug Alcohol Depend Rep. Sep 2024;12:100281. [FREE Full text] [CrossRef] [Medline]
- Coulter RWS, Ware D, Fish JN, Plankey MW. Latent classes of polysubstance use among adolescents in the United States: intersections of sexual identity with sex, age, and race/ethnicity. LGBT Health. Apr 2019;6(3):116-125. [FREE Full text] [CrossRef] [Medline]
- Lee J, Evans-Polce RJ, Ahlquist J, Parker MA. Polysubstance use by sexual identity among US adults, 2021. Prev Med. Dec 2023;177:107729. [CrossRef] [Medline]
- Nguyen-Grozavu FT, Pierce JP, Sakuma KK, Leas EC, McMenamin SB, Kealey S, et al. Widening disparities in cigarette smoking by race/ethnicity across education level in the United States. Prev Med. Oct 2020;139:106220. [FREE Full text] [CrossRef] [Medline]
Abbreviations
| aOR: adjusted odds ratio |
| BIPOC: Black, Indigenous, people of color |
| SGM: sexual and gender minoritized |
Edited by A Mavragani, T Sanchez; submitted 12.08.25; peer-reviewed by J Lee, D Smith; comments to author 03.09.25; revised version received 03.09.25; accepted 06.09.25; published 12.09.25.
Copyright©Jarett Maycott, Sean Arayasirikul. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 12.09.2025.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Public Health and Surveillance, is properly cited. The complete bibliographic information, a link to the original publication on https://publichealth.jmir.org, as well as this copyright and license information must be included.

